Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice

1.

Termine JD, Belcourt AB, Christner PJ, Conn KM, Nylen MU. Properties of dissociatively extracted fetal

tooth matrix proteins. I. Principal molecular species in developing bovine enamel. J Biol Chem. 1980;

255: 9760–9768. PMID: 7430099

2.

Bartlett JD, Simmer JP, Xue J, Margolis HC, Moreno EC. Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene. 1996; 183: 123–

128. https://doi.org/10.1016/s0378-1119(96)00525-2 PMID: 8996096

3.

Simmer JP, Hu JCC. Expression, structure, and function of enamel proteinases. Connect Tissue Res.

2002; 43: 441–9. https://doi.org/10.1080/03008200290001159 PMID: 12489196

4.

Smith CE. Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med. 1998; 9:

128–61. https://doi.org/10.1177/10454411980090020101 PMID: 9603233

5.

Wright JT, Butler WT. Alteration of Enamel Proteins in Hypomaturation Amelogenesis Imperfecta. J

Dent Res. 1989; 68: 1328–1330. https://doi.org/10.1177/00220345890680090801 PMID: 2674234

6.

Collier PM, Sauk JJ, Rosenbloom SJ, Yuan ZA, Gibson CW. An amelogenin gene defect associated

with human X-linked amelogenesis imperfecta. Arch Oral Biol. 1997; 42: 235–42. https://doi.org/10.

1016/s0003-9969(96)00099-4 PMID: 9188994

7.

Lagerstro¨m M, Dahl N, Nakahori Y, Nakagome Y, Ba¨ckman B, Landegren U, et al. A deletion in the

amelogenin gene (AMG) causes X-linked amelogenesis imperfecta (AIH1). Genomics. 1991; 10: 971–

5. https://doi.org/10.1016/0888-7543(91)90187-j PMID: 1916828

8.

Wright JT, Hall KI, Yamauche M. The enamel proteins in human amelogenesis imperfecta. Arch Oral

Biol. 1997; 42: 149–59. https://doi.org/10.1016/s0003-9969(96)00096-9 PMID: 9134127

PLOS ONE | https://doi.org/10.1371/journal.pone.0259966 November 15, 2021

16 / 19

PLOS ONE

Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice

9.

Gibson CW, Yuan ZA, Hall B, Longenecker G, Chen E, Thyagarajan T, et al. Amelogenin-deficient mice

display an amelogenesis imperfecta phenotype. J Biol Chem. 2001; 276: 31871–5. https://doi.org/10.

1074/jbc.M104624200 PMID: 11406633

10.

Hu CC, Ryu OH, Qian Q, Zhang CH, Simmer JP. Cloning, characterization, and heterologous expression of exon-4-containing amelogenin mRNAs. J Dent Res. 1997; 76: 641–647. https://doi.org/10.1177/

00220345970760020401 PMID: 9062557

11.

Li Y, Yuan Z-A, Aragon MA, Kulkarni AB, Gibson CW. Comparison of body weight and gene expression

in amelogenin null and wild-type mice. Eur J Oral Sci. 2006; 114 Suppl: 190–192,381. https://doi.org/10.

1111/j.1600-0722.2006.00286.x PMID: 16674684

12.

Bartlett JD, Ball RL, Kawai T, Tye CE, Tsuchiya M, Simmer JP. Origin, splicing, and expression of

rodent amelogenin exon 8. J Dent Res. 2006; 85: 894–899. https://doi.org/10.1177/

154405910608501004 PMID: 16998127

13.

Papagerakis P, Ibarra JM, Inozentseva N, DenBesten P, MacDougall M. Mouse amelogenin exons 8

and 9: sequence analysis and protein distribution. J Dent Res. 2005; 84: 613–617. https://doi.org/10.

1177/154405910508400706 PMID: 15972588

14.

Gibson CW, Thomson NH, Abrams WR, Kirkham J. Nested genes: biological implications and use of

AFM for analysis. Gene. 2005; 350: 15–23. https://doi.org/10.1016/j.gene.2004.12.045 PMID:

15780979

15.

Veis A. Amelogenin gene splice products: potential signaling molecules. Cell Mol Life Sci. 2003; 60: 38–

55. https://doi.org/10.1007/s000180300003 PMID: 12613657

16.

Ravindranath HH, Chen L-S, Zeichner-David M, Ishima R, Ravindranath RMH. Interaction between the

enamel matrix proteins amelogenin and ameloblastin. Biochem Biophys Res Commun. 2004; 323:

1075–1083. https://doi.org/10.1016/j.bbrc.2004.08.207 PMID: 15381109

17.

Gibson CW, Yuan ZA, Li Y, Daly B, Suggs C, Aragon MA, et al. Transgenic mice that express normal

and mutated amelogenins. J Dent Res. 2007; 86: 331–335. https://doi.org/10.1177/

154405910708600406 PMID: 17384027

18.

Li Y, Suggs C, Wright JT, Yuan Z, Aragon M, Fong H, et al. Partial rescue of the amelogenin null dental

enamel phenotype. J Biol Chem. 2008; 283: 15056–15062. https://doi.org/10.1074/jbc.M707992200

PMID: 18390542

19.

Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci. 2008; 121: 255–264. https://doi.org/10.1242/jcs.006064 PMID: 18216330

20.

Jadlowiec J, Koch H, Zhang X, Campbell PG, Seyedain M, Sfeir C. Phosphophoryn regulates the gene

expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the

integrin/MAPK signaling pathway. J Biol Chem. 2004; 279: 53323–53330. https://doi.org/10.1074/jbc.

M404934200 PMID: 15371433

21.

Eapen A, Ramachandran A, George A. Dentin phosphoprotein (DPP) activates integrin-mediated

anchorage-dependent signals in undifferentiated mesenchymal cells. J Biol Chem. 2012; 287: 5211–

5224. https://doi.org/10.1074/jbc.M111.290080 PMID: 22134916

22.

Narayanan K, Gajjeraman S, Ramachandran A, Hao J, George A. Dentin matrix protein 1 regulates

dentin sialophosphoprotein gene transcription during early odontoblast differentiation. J Biol Chem.

2006; 281: 19064–19071. https://doi.org/10.1074/jbc.M600714200 PMID: 16679514

23.

Deutsch D, Haze-Filderman A, Blumenfeld A, Dafni L, Leiser Y, Shay B, et al. Amelogenin, a major

structural protein in mineralizing enamel, is also expressed in soft tissues: brain and cells of the hematopoietic system. Eur J Oral Sci. 2006; 114 Suppl: 182–183,381. https://doi.org/10.1111/j.1600-0722.

2006.00301.x PMID: 16674683

24.

Atsawasuwan P, Lu X, Ito Y, Chen Y, Gopinathan G, Evans CA, et al. Expression and function of

enamel-related gene products in calvarial development. J Dent Res. 2013; 92: 622–8. https://doi.org/

10.1177/0022034513487906 PMID: 23625374

25.

Simmer JP, Hu CC, Lau EC, Sarte P, Slavkin HC, Fincham AG. Alternative splicing of the mouse amelogenin primary RNA transcript. Calcif Tissue Int. 1994; 55: 302–310. https://doi.org/10.1007/

BF00310410 PMID: 7820782

26.

Veis A, Tompkins K, Alvares K, Wei K, Wang L, Wang XS, et al. Specific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo. J Biol Chem. 2000; 275: 41263–

41272. https://doi.org/10.1074/jbc.M002308200 PMID: 10998415

27.

Viswanathan HL, Berry JE, Foster BL, Gibson CW, Li Y, Kulkarni AB, et al. Amelogenin: a potential regulator of cementum-associated genes. J Periodontol. 2003; 74: 1423–1431. https://doi.org/10.1902/jop.

2003.74.10.1423 PMID: 14653387

28.

Hatakeyama J, Sreenath T, Hatakeyama Y, Thyagarajan T, Shum L, Gibson CW, et al. The receptor

activator of nuclear factor-kappa B ligand-mediated osteoclastogenic pathway is elevated in

PLOS ONE | https://doi.org/10.1371/journal.pone.0259966 November 15, 2021

17 / 19

PLOS ONE

Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice

amelogenin-null mice. J Biol Chem. 2003; 278: 35743–35748. https://doi.org/10.1074/jbc.M306284200

PMID: 12851394

29.

Hammarstro¨m L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol. 1997; 24: 669–677. https://doi.org/

10.1111/j.1600-051x.1997.tb00248.x PMID: 9310871

30.

Gestrelius S, Andersson C, Lidstro¨m D, Hammarstro¨m L, Somerman M. In vitro studies on periodontal

ligament cells and enamel matrix derivative. J Clin Periodontol. 1997; 24: 685–692. https://doi.org/10.

1111/j.1600-051x.1997.tb00250.x PMID: 9310873

31.

Cardaropoli G, Leonhardt AS. Enamel matrix proteins in the treatment of deep intrabony defects. J Periodontol. 2002; 73: 501–504. https://doi.org/10.1902/jop.2002.73.5.501 PMID: 12027251

32.

Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used

alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects

in humans. J Periodontol. 2002; 73: 433–440. https://doi.org/10.1902/jop.2002.73.4.433 PMID:

11990445

33.

Lyngstadaas SP, Wohlfahrt JC, Brookes SJ, Paine ML, Snead ML, Reseland JE. Enamel matrix proteins; old molecules for new applications. Orthod Craniofac Res. 2009; 12: 243–53. https://doi.org/10.

1111/j.1601-6343.2009.01459.x PMID: 19627527

34.

Shimizu E, Saito R, Nakayama Y, Nakajima Y, Kato N, Takai H, et al. Amelogenin stimulates bone sialoprotein (BSP) expression through fibroblast growth factor 2 response element and transforming growth

factor-beta1 activation element in the promoter of the BSP gene. J Periodontol. 2005; 76: 1482–1489.

https://doi.org/10.1902/jop.2005.76.9.1482 PMID: 16171436

35.

Warotayanont R, Frenkel B, Snead ML, Zhou Y. Leucine-rich amelogenin peptide induces osteogenesis

by activation of the Wnt pathway. Biochem Biophys Res Commun. 2009; 387: 558–563. https://doi.org/

10.1016/j.bbrc.2009.07.058 PMID: 19615979

36.

Hatakeyama J, Philp D, Hatakeyama Y, Haruyama N, Shum L, Aragon MA, et al. Amelogenin-mediated

regulation of osteoclastogenesis, and periodontal cell proliferation and migration. J Dent Res. 2006; 85:

144–149. https://doi.org/10.1177/154405910608500206 PMID: 16434732

37.

Rossert J, Eberspaecher H, de Crombrugghe B. Separate cis-acting DNA elements of the mouse proalpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing

cells in transgenic mice. J Cell Biol. 1995; 129: 1421–1432. https://doi.org/10.1083/jcb.129.5.1421

PMID: 7775585

38.

Cho A, Haruyama N, Kulkarni AB. Generation of transgenic mice. Curr Protoc Cell Biol. 2009. https://

doi.org/10.1002/0471143030.cb1911s42 PMID: 19283729

39.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR

and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402–408. https://doi.org/10.1006/meth.2001.

1262 PMID: 11846609

40.

Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res.

2003; 31: e154. https://doi.org/10.1093/nar/gng154 PMID: 14654707

41.

Gibson CW, Kucich U, Collier P, Shen G, Decker S, Bashir M, et al. Analysis of amelogenin proteins

using monospecific antibodies to defined sequences. Connect Tissue Res. 1995; 32: 109–114. https://

doi.org/10.3109/03008209509013711 PMID: 7554905

42.

Campbell GM, Sophocleous A. Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies. Bonekey Rep. 2014; 3: 564. https://doi.org/10.1038/

bonekey.2014.59 PMID: 25184037

43.

Wagenaar-Miller RA, Engelholm LH, Gavard J, Yamada SS, Gutkind JS, Behrendt N, et al. Complementary roles of intracellular and pericellular collagen degradation pathways in vivo. Mol Cell Biol.

2007; 27: 6309–6322. https://doi.org/10.1128/MCB.00291-07 PMID: 17620416

44.

Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1

results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89:

755–64. https://doi.org/10.1016/s0092-8674(00)80258-5 PMID: 9182763

45.

Xiang A, Kanematsu M, Kumar S, Yamashita D, Kaise T, Kikkawa H, et al. Changes in micro-CT 3D

bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and

cortical bone formation in ovariectomized mice. Bone. 2007; 40: 1231–1237. https://doi.org/10.1016/j.

bone.2007.01.010 PMID: 17347064

46.

Bou-Gharios G, Garrett LA, Rossert J, Niederreither K, Eberspaecher H, Smith C, et al. A potent farupstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in

transgenic mice. J Cell Biol. 1996; 134: 1333–1344. https://doi.org/10.1083/jcb.134.5.1333 PMID:

8794872

PLOS ONE | https://doi.org/10.1371/journal.pone.0259966 November 15, 2021

18 / 19

PLOS ONE

Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice

47.

Warotayanont R, Zhu D, Snead ML, Zhou Y. Leucine-rich amelogenin peptide induces osteogenesis in

mouse embryonic stem cells. Biochem Biophys Res Commun. 2008; 367: 1–6. https://doi.org/10.1016/

j.bbrc.2007.12.048 PMID: 18086559

48.

Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of postmenopausal osteoporosis. J Dent Res. 2006; 85: 596–607. https://doi.org/10.1177/

154405910608500704 PMID: 16798858

49.

Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J bone Miner Res

Off J Am Soc Bone Miner Res. 1996; 11: 1043–1051. https://doi.org/10.1002/jbmr.5650110802 PMID:

8854239

50.

Raisz LG. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr. 1995; 125: 2024S–2027S. https://doi.org/10.1093/jn/125.suppl_7.2024S PMID: 7602387

51.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to

TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998; 95: 3597–3602. https://doi.org/10.1073/pnas.95.7.

3597 PMID: 9520411

52.

Iacob S, Veis A. Identification of the functional activity of the [A-4] amelogenin gene splice product in

newborn mouse ameloblasts. Bone. 2008; 42: 1072–1079. https://doi.org/10.1016/j.bone.2008.01.023

PMID: 18394981

53.

van’t Hof RJ, Ralston SH. Nitric oxide and bone. Immunology. 2001; 103: 255–261. https://doi.org/10.

1046/j.1365-2567.2001.01261.x PMID: 11454054

54.

Fan X, Roy E, Zhu L, Murphy TC, Ackert-Bicknell C, Hart CM, et al. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.

Endocrinology. 2004; 145: 751–759. https://doi.org/10.1210/en.2003-0726 PMID: 14563699

55.

Tompkins K, George A, Veis A. Characterization of a mouse amelogenin [A-4]/M59 cell surface receptor. Bone. 2006; 38: 172–180. https://doi.org/10.1016/j.bone.2005.08.013 PMID: 16214432

56.

Zou Y, Wang H, Shapiro JL, Okamoto CT, Brookes SJ, Lyngstadaas SP, et al. Determination of protein

regions responsible for interactions of amelogenin with CD63 and LAMP1. Biochem J. 2007; 408: 347–

354. https://doi.org/10.1042/BJ20070881 PMID: 17708745

57.

Shapiro JL, Wen X, Okamoto CT, Wang HJ, Lyngstadaas SP, Goldberg M, et al. Cellular uptake of

amelogenin, and its localization to CD63, and Lamp1-positive vesicles. Cell Mol Life Sci. 2007; 64: 244–

256. https://doi.org/10.1007/s00018-006-6429-4 PMID: 17187173

58.

Stewart K, Monk P, Walsh S, Jefferiss CM, Letchford J, Beresford JN. STRO-1, HOP-26 (CD63),

CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res. 2003; 313: 281–290. https://doi.

org/10.1007/s00441-003-0762-9 PMID: 12883998

59.

Haruyama N, Hatakeyama J, Moriyama K, Kulkarni AB. Amelogenins: Multi-Functional Enamel Matrix

Proteins and Their Binding Partners. J oral Biosci. 2011; 53: 257–266. Available: http://www.ncbi.nlm.

nih.gov/pubmed/23914134 PMID: 23914134

PLOS ONE | https://doi.org/10.1371/journal.pone.0259966 November 15, 2021

19 / 19

...